+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 3
Age: 41Years - 81Years
All Genders
ID07498426

Evaluating the Safety and Effectiveness of NIO752 Compared to Placebo in Adults with Progressive Supranuclear Palsy A Randomized, Double-Blind, Placebo-Controlled Phase III Trial with Open-Label Extension

Led by Novartis Pharmaceuticals · Updated on 2026-10-15

300

Participants Needed

64

Research Sites

104 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the efficacy and safety of NIO752 in people with Progressive Supranuclear Palsy PSP in this Phase III randomized, placebo-controlled study. The trial aims to understand how well NIO752 works in treating PSP Richardson syndrome, a condition characterized by certain neurological symptoms with onset less than 5 years ago. Participants with mild to moderate PSP and specific functional abilities are included to assess the treatments impact. Participants will be randomly assigned in a 21 ratio to receive either NIO752, an antisense oligonucleotide solution, or a placebo solution. This double-blind treatment phase is followed by an open-label extension where all participants can continue receiving NIO752. The study measures changes in disease severity and function over 72 weeks using several scales and cognitive tests. During the study, participants and their reliable study partners will attend visits for assessments including neurological exams, cognitive tests, and brain MRI scans. Researchers will monitor changes in PSP rating scales, daily living activities, cognitive function, and relevant biomarkers in cerebrospinal fluid. Safety is closely tracked through adverse event reporting. The total study duration includes 72 weeks of treatment followed by long-term monitoring until study completion.

CONDITIONS

Brief Title

A Study to Evaluate the Efficacy of NIO752 in Participants With Progressive Supranuclear Palsy

Research Team

N

Novartis Pharmaceuticals

N

Novartis Pharmaceuticals

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here